Table 5

Referral to palliative care services in the last 3 months of life of hospitalised patients with different haematological malignancies

Total study populationAcute leukaemiaChronic lymphoid leukaemiaChronic myeloid leukaemiaHodgkin’s lymphomaMultiple myelomaMyelodysplastic syndromesNon-Hodgkin’s lymphoma
n=46 629n=11 531n=4161n=1157n=1022n=8803n=6693n=13 262
n (%)*n (%)*n (%)*n (%)*n (%)*n (%)*n (%)*n (%)*
Reporting of palliative status†
 30 days before death6916 (14.8)1832 (15.9)455 (10.9)155 (13.4)144 (14.1)1276 (14.5)741 (11.1)2314 (17.5)
 15 before death12 312 (26.4)3249 (28.2)831 (20.0)251 (21.7)278 (27.2)2403 (27.3)1319 (19.7)3982 (30.0)
 7 days before death16 884 (36.2)4588 (39.8)1139 (27.4)342 (29.5)353 (34.5)3302 (37.5)1842 (27.5)5319 (40.1)
 Day of death21 863 (46.9)6119 (53.1)1520 (36.5)447 (38.6)430 (42.0)4320 (49.1)2380 (35.6)6650 (50.1)
 Palliative status was not reported‡24 766 (53.1)5413 (46.9)2641 (63.5)711 (61.4)593 (58.0)4484 (50.9)4313 (64.4)6612 (49.9)
Inpatient palliative care unit
 Admission2799 (6.0)772 (6.7)146 (3.5)61 (5.3)42 (4.1)551 (6.3)295 (4.4)930 (7.0)
 Death2583 (5.5)722 (6.3)137 (3.3)59 (5.1)35 (3.4)509 (5.8)277 (4.1)845 (6.4)
Palliative care support bed
 Admission5843 (12.5)1607 (13.9)410 (9.9)98 (8.5)117 (11.4)1183 (13.4)511 (7.6)1917 (14.5)
 Death4939 (11.9)1356 (12.8)340 (9.1)78 (7.8)97 (10.8)997 (12.9)453 (7.6)1618 (14.1)
  • *Sex-standardised and age-standardised values, using the total study population as reference.

  • †Cumulative percentage.

  • ‡During the last 3 months of life.